.
This commit is contained in:
@@ -2094,83 +2094,326 @@ All records of the Company and its series shall be maintained exclusively in ele
|
|||||||
#### 4.5.1 - Cell Series Establishment
|
#### 4.5.1 - Cell Series Establishment
|
||||||
|
|
||||||
1. **Creation Requirements**: Establishment of a Cell Series requires:
|
1. **Creation Requirements**: Establishment of a Cell Series requires:
|
||||||
a. Explicit Board approval by a two-thirds majority vote;
|
|
||||||
b. Filing of required notices with the Texas Secretary of State;
|
* Explicit Board approval by a two-thirds majority vote
|
||||||
c. Execution of a cell series operating agreement; and
|
|
||||||
d. Compliance with all applicable regulatory requirements.
|
* Filing of required notices with the Texas Secretary of State
|
||||||
|
|
||||||
|
* Execution of a cell series operating agreement
|
||||||
|
|
||||||
|
* Compliance with all applicable regulatory requirements
|
||||||
|
|
||||||
|
* Completion of a comprehensive business plan and risk assessment
|
||||||
|
|
||||||
|
* Identification of initial subsidiary series to be created
|
||||||
|
|
||||||
|
* Implementation of enhanced governance and compliance systems
|
||||||
|
|
||||||
2. **Cell Purpose Statement**: The proposal for a Cell Series must include a detailed purpose statement describing:
|
2. **Cell Purpose Statement**: The proposal for a Cell Series must include a detailed purpose statement describing:
|
||||||
a. Strategic rationale for the cell structure;
|
|
||||||
b. Types of subsidiary series to be created;
|
* Strategic rationale for the cell structure
|
||||||
c. Governance relationship with the Company;
|
|
||||||
d. Economic structure and capital requirements; and
|
* Types of subsidiary series to be created
|
||||||
e. Risk management framework.
|
|
||||||
|
* Governance relationship with the Company
|
||||||
|
|
||||||
|
* Economic structure and capital requirements
|
||||||
|
|
||||||
|
* Risk management framework
|
||||||
|
|
||||||
|
* Target markets and business objectives
|
||||||
|
|
||||||
|
* Projected financial performance
|
||||||
|
|
||||||
|
* Long-term growth and development plans
|
||||||
|
|
||||||
|
* Competitive analysis and market positioning
|
||||||
|
|
||||||
|
* Exit strategy or long-term sustainability plan
|
||||||
|
|
||||||
|
3. **Capitalization Requirements**:
|
||||||
|
|
||||||
|
* Minimum initial capitalization as determined by the Board
|
||||||
|
|
||||||
|
* Capital adequacy framework appropriate to planned activities
|
||||||
|
|
||||||
|
* Funding mechanisms for subsidiary series
|
||||||
|
|
||||||
|
* Reserve requirements for operational contingencies
|
||||||
|
|
||||||
|
* Capital deployment schedules and milestones
|
||||||
|
|
||||||
|
* Financial covenants to ensure ongoing solvency
|
||||||
|
|
||||||
|
* Quarterly financial reporting to the Board
|
||||||
|
|
||||||
#### 4.5.2 - Cell Series Governance
|
#### 4.5.2 - Cell Series Governance
|
||||||
|
|
||||||
1. **Independent Governance**: A Cell Series may:
|
1. **Independent Governance**: A Cell Series may:
|
||||||
a. Establish and maintain an independent Series board;
|
|
||||||
b. Create specialized governance committees;
|
* Establish and maintain an independent Series board
|
||||||
c. Implement governance structures independent from the Company Committee; and
|
|
||||||
d. Develop its own policies and procedures.
|
* Create specialized governance committees
|
||||||
|
|
||||||
|
* Implement governance structures independent from the Company Committee
|
||||||
|
|
||||||
|
* Develop its own policies and procedures
|
||||||
|
|
||||||
|
* Establish executive leadership positions
|
||||||
|
|
||||||
|
* Implement unique incentive and compensation structures
|
||||||
|
|
||||||
|
* Develop proprietary operating procedures
|
||||||
|
|
||||||
2. **Governance Requirements**: All Cell Series must:
|
2. **Governance Requirements**: All Cell Series must:
|
||||||
a. Document governance structures in the cell series operating agreement;
|
|
||||||
b. Establish clear reporting relationships to the Board;
|
* Document governance structures in the cell series operating agreement
|
||||||
c. Implement appropriate controls and compliance measures;
|
|
||||||
d. Maintain compliance with Company requirements; and
|
* Establish clear reporting relationships to the Board
|
||||||
e. Submit quarterly governance reports to the Board.
|
|
||||||
|
* Implement appropriate controls and compliance measures
|
||||||
|
|
||||||
|
* Maintain compliance with Company requirements
|
||||||
|
|
||||||
|
* Submit quarterly governance reports to the Board
|
||||||
|
|
||||||
|
* Conduct annual governance effectiveness reviews
|
||||||
|
|
||||||
|
* Implement succession planning for key leadership positions
|
||||||
|
|
||||||
|
* Maintain appropriate committee structures
|
||||||
|
|
||||||
|
* Document all governance decisions in the electronic records system
|
||||||
|
|
||||||
|
3. **Oversight and Accountability**:
|
||||||
|
|
||||||
|
* Cell Series boards shall be accountable to the Board
|
||||||
|
|
||||||
|
* Annual performance evaluations of the Cell Series board
|
||||||
|
|
||||||
|
* Regular governance audits by the Company Committee
|
||||||
|
|
||||||
|
* Transparency in decision-making processes
|
||||||
|
|
||||||
|
* Conflicts of interest management and disclosure
|
||||||
|
|
||||||
|
* Ethics and compliance program appropriate to activities
|
||||||
|
|
||||||
|
* Whistleblower protection mechanisms
|
||||||
|
|
||||||
|
* Direct reporting line to the Board for compliance concerns
|
||||||
|
|
||||||
#### 4.5.3 - Cell Series Structure
|
#### 4.5.3 - Cell Series Structure
|
||||||
|
|
||||||
1. **Multi-Series Framework**: A Cell Series:
|
1. **Multi-Series Framework**: A Cell Series:
|
||||||
a. May contain multiple subsidiary series;
|
|
||||||
b. Provides administrative oversight for all subsidiary series;
|
* May contain multiple subsidiary series
|
||||||
c. Establishes common policies across subsidiary series; and
|
|
||||||
d. Maintains compliance for the entire cell structure.
|
* Provides administrative oversight for all subsidiary series
|
||||||
|
|
||||||
|
* Establishes common policies across subsidiary series
|
||||||
|
|
||||||
|
* Maintains compliance for the entire cell structure
|
||||||
|
|
||||||
|
* Implements standardized operating procedures
|
||||||
|
|
||||||
|
* Provides shared services to subsidiary series
|
||||||
|
|
||||||
|
* Coordinates strategic planning across subsidiary series
|
||||||
|
|
||||||
|
* Establishes branding and market positioning
|
||||||
|
|
||||||
2. **Subsidiary Independence**: Each subsidiary series within a Cell Series:
|
2. **Subsidiary Independence**: Each subsidiary series within a Cell Series:
|
||||||
a. Maintains complete asset and liability isolation;
|
|
||||||
b. Operates independently according to its specific purpose;
|
* Maintains complete asset and liability isolation
|
||||||
c. Has its own membership interests; and
|
|
||||||
d. Is subject to all provisions of Section 4.2.
|
* Operates independently according to its specific purpose
|
||||||
|
|
||||||
|
* Has its own membership interests
|
||||||
|
|
||||||
|
* Is subject to all provisions of Section 4.2
|
||||||
|
|
||||||
|
* Maintains separate financial records
|
||||||
|
|
||||||
|
* Has its own governance structure within cell framework
|
||||||
|
|
||||||
|
* Retains operational autonomy within cell policies
|
||||||
|
|
||||||
|
* May have distinct branding and market positioning
|
||||||
|
|
||||||
|
3. **Inter-Series Relationships**:
|
||||||
|
|
||||||
|
* Formal service agreements must exist between Cell Series and subsidiary series
|
||||||
|
|
||||||
|
* All inter-series transactions must be at fair market value
|
||||||
|
|
||||||
|
* Resource sharing must be documented with clear allocation methodologies
|
||||||
|
|
||||||
|
* Cost sharing arrangements must be formalized and equitable
|
||||||
|
|
||||||
|
* Intellectual property licensing must be properly documented
|
||||||
|
|
||||||
|
* Personnel sharing must follow Section 4.2.2(4)
|
||||||
|
|
||||||
|
* Transfer pricing documentation must be maintained
|
||||||
|
|
||||||
#### 4.5.4 - Subsidiary Series Creation
|
#### 4.5.4 - Subsidiary Series Creation
|
||||||
|
|
||||||
1. **Creation Authority**: A Cell Series may create subsidiary series:
|
1. **Creation Authority**: A Cell Series may create subsidiary series:
|
||||||
a. Under its own authority as established in its cell series operating agreement;
|
|
||||||
b. Without requiring specific Company Board approval for each subsidiary;
|
* Under its own authority as established in its cell series operating agreement
|
||||||
c. Subject to any limitations in its cell series operating agreement; and
|
|
||||||
d. In compliance with all requirements of this Agreement.
|
* Without requiring specific Company Board approval for each subsidiary
|
||||||
|
|
||||||
|
* Subject to any limitations in its cell series operating agreement
|
||||||
|
|
||||||
|
* In compliance with all requirements of this Agreement
|
||||||
|
|
||||||
|
* Following standardized establishment procedures
|
||||||
|
|
||||||
|
* With proper capitalization and business planning
|
||||||
|
|
||||||
|
* After appropriate market and risk assessment
|
||||||
|
|
||||||
2. **Documentation Requirements**: For each subsidiary series created, the Cell Series must:
|
2. **Documentation Requirements**: For each subsidiary series created, the Cell Series must:
|
||||||
a. File all required notices with the Texas Secretary of State;
|
|
||||||
b. Execute a subsidiary series operating agreement;
|
* File all required notices with the Texas Secretary of State
|
||||||
c. Establish separate books and records;
|
|
||||||
d. Obtain a separate EIN if required; and
|
* Execute a subsidiary series operating agreement
|
||||||
e. Notify the Company Committee within 10 business days of creation.
|
|
||||||
|
* Establish separate books and records
|
||||||
|
|
||||||
|
* Obtain a separate EIN if required
|
||||||
|
|
||||||
|
* Notify the Company Committee within 10 business days of creation
|
||||||
|
|
||||||
|
* Implement required compliance and governance systems
|
||||||
|
|
||||||
|
* Establish appropriate banking and financial accounts
|
||||||
|
|
||||||
|
* Document the business purpose and operational parameters
|
||||||
|
|
||||||
|
* Implement required securities law compliance measures
|
||||||
|
|
||||||
|
3. **Establishment Standards**:
|
||||||
|
|
||||||
|
* Cell Series shall develop standardized criteria for subsidiary creation
|
||||||
|
|
||||||
|
* Formal feasibility and due diligence process shall be documented
|
||||||
|
|
||||||
|
* Minimum viability metrics shall be established
|
||||||
|
|
||||||
|
* Anti-cannibalization analysis for overlap with existing series
|
||||||
|
|
||||||
|
* Competitive impact assessment within TSYS Group
|
||||||
|
|
||||||
|
* Resource allocation planning
|
||||||
|
|
||||||
|
* Market entry strategy
|
||||||
|
|
||||||
|
* Personnel requirements and sourcing plans
|
||||||
|
|
||||||
#### 4.5.5 - Cell Series Board Powers
|
#### 4.5.5 - Cell Series Board Powers
|
||||||
|
|
||||||
1. **Authorized Powers**: A Cell Series board shall have authority to:
|
1. **Authorized Powers**: A Cell Series board shall have authority to:
|
||||||
a. Establish subsidiary series;
|
|
||||||
b. Set internal governance policies;
|
* Establish subsidiary series
|
||||||
c. Approve subsidiary series actions;
|
|
||||||
d. Monitor subsidiary compliance;
|
* Set internal governance policies
|
||||||
e. Manage resource allocation across the cell; and
|
|
||||||
f. Implement strategic initiatives within the cell.
|
* Approve subsidiary series actions
|
||||||
|
|
||||||
|
* Monitor subsidiary compliance
|
||||||
|
|
||||||
|
* Manage resource allocation across the cell
|
||||||
|
|
||||||
|
* Implement strategic initiatives within the cell
|
||||||
|
|
||||||
|
* Establish compensation structures
|
||||||
|
|
||||||
|
* Approve significant contracts and commitments
|
||||||
|
|
||||||
|
* Manage capital deployment within the cell
|
||||||
|
|
||||||
|
* Resolve disputes between subsidiary series
|
||||||
|
|
||||||
|
* Approve merger or acquisition activities
|
||||||
|
|
||||||
|
* Oversee risk management
|
||||||
|
|
||||||
2. **Limitations on Powers**: A Cell Series board may not:
|
2. **Limitations on Powers**: A Cell Series board may not:
|
||||||
a. Override Company service provider requirements;
|
|
||||||
b. Violate or modify any provisions of this Agreement;
|
* Override Company service provider requirements
|
||||||
c. Create obligations binding on the Company or other series; or
|
|
||||||
d. Take any action that would threaten series isolation.
|
* Violate or modify any provisions of this Agreement
|
||||||
|
|
||||||
|
* Create obligations binding on the Company or other series
|
||||||
|
|
||||||
|
* Take any action that would threaten series isolation
|
||||||
|
|
||||||
|
* Issue securities non-compliant with Article 5
|
||||||
|
|
||||||
|
* Modify the capital raising requirements in Section 3.3
|
||||||
|
|
||||||
|
* Establish governance structures in conflict with this Agreement
|
||||||
|
|
||||||
|
* Enter into agreements binding the Company
|
||||||
|
|
||||||
|
* Create cross-series liability or guarantees
|
||||||
|
|
||||||
3. **Compliance Oversight**: Each Cell Series shall be subject to:
|
3. **Compliance Oversight**: Each Cell Series shall be subject to:
|
||||||
a. Company Committee oversight for overall compliance;
|
|
||||||
b. Annual compliance audits;
|
* Company Committee oversight for overall compliance
|
||||||
c. Regular reporting requirements; and
|
|
||||||
d. Remediation obligations for any identified compliance issues.
|
* Annual compliance audits
|
||||||
|
|
||||||
|
* Regular reporting requirements
|
||||||
|
|
||||||
|
* Remediation obligations for any identified compliance issues
|
||||||
|
|
||||||
|
* Risk-based monitoring by appropriate Board committees
|
||||||
|
|
||||||
|
* Periodic governance reviews
|
||||||
|
|
||||||
|
* Compliance with all regulatory requirements
|
||||||
|
|
||||||
|
* Implementation of recommended remedial measures
|
||||||
|
|
||||||
|
4. **Strategic Planning Authority**:
|
||||||
|
|
||||||
|
* Development of multi-year strategic plans for the Cell Series
|
||||||
|
|
||||||
|
* Resource allocation across subsidiary series
|
||||||
|
|
||||||
|
* Capital deployment planning and prioritization
|
||||||
|
|
||||||
|
* Market development and expansion strategies
|
||||||
|
|
||||||
|
* Technology roadmap development
|
||||||
|
|
||||||
|
* Talent acquisition and development programs
|
||||||
|
|
||||||
|
* Innovation and research initiatives
|
||||||
|
|
||||||
|
* Strategic partnership development
|
||||||
|
|
||||||
|
5. **Financial Management Powers**:
|
||||||
|
|
||||||
|
* Budget approval for the Cell Series and subsidiaries
|
||||||
|
|
||||||
|
* Capital expenditure authorization within approved limits
|
||||||
|
|
||||||
|
* Financial performance monitoring and intervention when necessary
|
||||||
|
|
||||||
|
* Reserve policy implementation
|
||||||
|
|
||||||
|
* Distribution approval in accordance with operating agreements
|
||||||
|
|
||||||
|
* Financial restructuring of subsidiary series when necessary
|
||||||
|
|
||||||
|
* Implementation of financial controls
|
||||||
|
|
||||||
|
* Audit oversight and response management
|
||||||
|
|
||||||
### Section 4.6 - Permanently Established Series
|
### Section 4.6 - Permanently Established Series
|
||||||
|
|
||||||
|
Reference in New Issue
Block a user